Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
SPINT2 encodes a transmembrane protein with two extracellular Kunitz domains that inhibits a variety of serine proteases. Additionally we are shipping SPINT2 Proteins (17) and SPINT2 Kits (8) and many more products for this protein.
Showing 10 out of 100 products:
Human Polyclonal SPINT2 Primary Antibody for ELISA, WB - ABIN4316550
Sivagnanam, Janecke, Müller, Heinz-Erian, Taylor, Bird: Case of syndromic tufting enteropathy harbors SPINT2 mutation seen in congenital sodium diarrhea. in Clinical dysmorphology 2009
Human Polyclonal SPINT2 Primary Antibody for IHC, IHC (p) - ABIN4316551
Friis, Sales, Schafer, Vogel, Kataoka, Bugge: The protease inhibitor HAI-2, but not HAI-1, regulates matriptase activation and shedding through prostasin. in The Journal of biological chemistry 2014
Our data indicate that hypoxic inhibition of JMJD3 (show Kdm6b Antibodies) activity reduces demethylation of H3K27me3, nucleosome removal, and hence induction of the STAT6 (show STAT6 Antibodies) target gene CCL18 (show CCL18 Antibodies), while induction of other STAT6 (show STAT6 Antibodies)-inducible genes such as SPINT2 remained unaffected by JMJD3 (show Kdm6b Antibodies).
Concomitant presence of TMPRSS13 (show TMPRSS13 Antibodies) with HAI-2 mediates phosphorylation of residues in the intracellular domain of the protease, and it coincides with efficient transport of the protease to the cell surface and its subsequent shedding.
This study presented a molecular characterization of congenital tufting enteropathy Italian patients, and identified one mutation in the SPINT2 gene
study the methylation status of the promoter region of Serine peptidase inhibitor/hepatocyte growth factor activator inhibitor type 2 (SPINT2/HAI-2)
It suggests an involvement of SPINT2 in PCa (show FLVCR1 Antibodies) tumorigenesis, probably in association with a post-translational regulation of SPINT2.
N-glycan branching regulates HAI-2 through different subcellular distribution and subsequently access to different target proteases
Matriptase (show ST14 Antibodies) inhibition by HAI-2 requires the translocation of HAI-2 to the cell surface, a process which is observed in some breast cancer cells but not in mammary epithelial cells.
Epigenetic silencing of SPINT2 promotes cancer cell motility in malignant melanoma.
a missense mutation in the serine protease inhibitor SPINT2 may have a role in congenital sodium diarrhea
results suggest that the SPINT2 underexpression in the MSC (show MSC Antibodies) from MDS (show PAFAH1B1 Antibodies) patients is probably involved in the adhesion of progenitors to the bone marrow niche, through an increased HGF (show HGF Antibodies) and SDF-1 (show CXCL12 Antibodies) signaling pathway.
HAI-1 (show SPINT1 Antibodies) regulates the activity of activated matriptase (show ST14 Antibodies), whereas HAI-2 has an essential role in regulating prostasin (show PRSS8 Antibodies)-dependent matriptase (show ST14 Antibodies) zymogen activation.
mutations in Prss8 (show PRSS8 Antibodies) restored placentation and normal development of HAI-1 (show SPINT1 Antibodies)-deficient embryos and prevented early embryonic lethality, mid-gestation lethality due to placental labyrinth failure, and neural tube defects in HAI-2-deficient embryos.
HAI-1 (show SPINT1 Antibodies) and -2 are overexpressed in the liver in cholangiopathies with ductular reactions and are possibly involved in liver fibrosis and hepatic differentiation.
Unlike HAI-1 (show SPINT1 Antibodies) and matriptase (show ST14 Antibodies), HAI-2 expression is detected in non-epithelial cells of brain and lymph nodes, suggesting that HAI-2 may also be involved in inhibition of serine proteases other than matriptase (show ST14 Antibodies)
Inhibition of the transmembrane serine protease (show F2 Antibodies) matriptase (show ST14 Antibodies) (encoded by St14 (show ST14 Antibodies)) is an essential function of HAI2 during tissue morphogenesis.
This gene encodes a transmembrane protein with two extracellular Kunitz domains that inhibits a variety of serine proteases. The protein inhibits HGF activator which prevents the formation of active hepatocyte growth factor. This gene is a putative tumor suppressor, and mutations in this gene result in congenital sodium diarrhea. Multiple transcript variants encoding different isoforms have been found for this gene.
hepatocyte growth factor activator inhibitor type 2
, placental bikunin
, serine protease inhibitor, Kunitz type 2
, kunitz-type protease inhibitor 2
, serine protease inhibitor, Kunitz type, 2